CD28 Targeted Co-Stimulatory Bispecific Antibodies for Treatment of Solid Tumors

By | 19 February 2026
  • Discovery of CD28 agonists
  • Indication specific development of CD28 targeted bispecific antibodies
  • Development of a CD28xNectin-4 bispecific for bladder cancer treatment